Session Type
Meeting
Search Results for NIS
Abstract Number: 117
Hospital Medicine 2020, Virtual Competition
Background: ST elevation MI is an acute event that mandates immediate intervention. Often, resources play a major role to enable prompt intervention. Our study aims to elaborate any differences that may exist between weekend and weekday outcomes at a national level. Methods: We conducted a retrospective analysis of the Nationwide Inpatient Sample (HCUP-NIS) database. Patients […]
Abstract Number: 122
SHM Converge 2021
Background: Although in-person hospitalist presence, increasingly staffed by dedicated nocturnists, has become the norm overnight in the hospital (1-2), the scope of nocturnist practice and the typical workload has not been defined. Methods: In November 2019 a survey was created by a panel of nocturnists made up of members of the SHM Night Medicine Special […]
Abstract Number: 124
SHM Converge 2023
Background: Axial spondyloarthritis (axSpA) takes two forms – radiographic (also known as ankylosing spondylitis(AS)) and non-radiographic (nr-axSpA). The symptoms caused are similar with chronic back pain, but nr-axSpA damage cannot be seen on X-rays. Historically, nonradiographic axial spondyloarthritis (nr-axSpA) did not have any approved codes so clinicians had to use AS and other codes. Starting […]
Abstract Number: 126
SHM Converge 2023
Background: Clinically, cough is classified by the duration which has implications for diagnosis and subsequent treatment. For example, chronic coughs lasting more than eight weeks, such as those related to allergies or gastroesophageal reflux disease, will have very different implications than acute coughs that less three weeks, such as those caused by the common cold. […]
Abstract Number: 127
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Revefenacin (REV), a once-daily, long-acting muscarinic antagonist for nebulized inhalation, was recently approved for maintenance treatment of chronic obstructive pulmonary disease (COPD). We present post hoc efficacy and safety data from three phase 3 trials in patients with moderate to very severe COPD by patient subgroup (<65 y, 65–75 y, >75 y). Methods: This […]
Abstract Number: 128
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Many patients with chronic obstructive pulmonary disease (COPD) have suboptimal peak inspiratory flow rate (sPIFR) because of lung hyperinflation, hypoxemia, and muscle wasting, preventing effective use of dry powder inhalers commonly used to treat COPD. sPIFR and airflow limitation interaction may be responsible for excess symptoms in patients with COPD. Here we characterize baseline […]
Abstract Number: 153
SHM Converge 2024
Background: Semaglutide, a Glucagon-like peptide-1 (GLP-1) agonist, has become one of the most prescribed medications as a result of its beneficial cardiovascular profile and beneficial side effect of weight loss. There is a paucity in literature about its adverse effects. We aimed to conduct a meta-analysis of the severe adverse effects (SAE) of Semaglutide using […]
Abstract Number: 172
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: The hands of hospitalists are often the source for transmitting multidrug resistant organisms (MDROs), and as such are the target of numerous hand hygiene interventions. Despite this focus, the prevalence of various MDROs on healthcare personnel (HCP) hands during routine patient care has not been well established. Therefore, we conducted a systematic review to: […]
Abstract Number: 174
Hospital Medicine 2020, Virtual Competition
Background: New Mexico has a long-standing history of implementing harm reduction strategies for the prevention of opioid overdose. Most recently, on June 14, 2019, SB221 added language to the New Mexico Pain Relief Act requiring health care providers prescribing opioid analgesics for 5 days or longer to co-prescribe an opioid antagonist along with written information […]
Abstract Number: 181
Hospital Medicine 2019, March 24-27, National Harbor, Md.
Background: Atrial fibrillation leads to increased risk of systemic embolism (SE) and stroke. To decrease the occurrence of stroke/SE, anticoagulation is routinely prescribed. Recently, non-vitamin K anticoagulants like apixaban and rivaroxaban have become more popular and are preferred over warfarin. We here compare the efficacy and safety of apixaban with warfarin. Methods: Eligible participants were […]